Familial combined hyperlipidemia: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lipoprotein disorder}} | |||
{{CMG}} | |||
{{SK}} Type IIB hyperlipoproteinemia | {{SK}} Type IIB hyperlipoproteinemia | ||
{{ | ==Overview== | ||
The high [[VLDL]] levels are due to overproduction of substrates, including triglycerides, [[acetyl-CoA]], and an increase in B-100 synthesis. They may also be caused by the decreased clearance of [[LDL]]. Prevalence in the population is 10%. | |||
==References== | |||
{{Reflist|2}} | |||
{{Lipopedia}} | {{Lipopedia}} | ||
[[Category:Cardiology]] | |||
[[Category:Disease]] | |||
[[Category:Lipopedia]] | [[Category:Lipopedia]] | ||
[[Category:Lipids]] | |||
[[Category:Up-To-Date]] | |||
{{WH}} | |||
{{WS}} | |||
Revision as of 13:36, 14 September 2013
Template:Lipoprotein disorder Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Type IIB hyperlipoproteinemia
Overview
The high VLDL levels are due to overproduction of substrates, including triglycerides, acetyl-CoA, and an increase in B-100 synthesis. They may also be caused by the decreased clearance of LDL. Prevalence in the population is 10%.